Eli Lilly and Co's GAAP net income for 9 months of 2023 was $3.051 billion, down 29.2% from $4.307 billion in the prior year. Revenue increased 16.6% to $24.77 billion from $21.24 billion a year earlier.

The Eli Lilly and Co Board of Directors announced a quarterly dividend of $1.13 per share. The last day to buy securities to receive the dividend is November 13, 2023. The annual dividend yield may reach 1.04%.

Eli Lilly's GAAP net income for 6 months of 2023 was $3.108 billion, up 8.9% from $2.855 billion in the prior year. Revenue increased 6.8% to $15.272 billion from $14.298 billion a year earlier.

Eli Lilly's GAAP net income for 3 months of 2023 was $1.345 billion, down 29.3% from $1.903 billion in the previous year. Revenues fell 10.9% to $6.96 billion from $7.81 billion a year earlier.